Results 91 to 100 of about 252,165 (283)

Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy

Andrology, EarlyView.
ABSTRACT Background Androgen receptors are highly expressed in upper body muscles, but changes in maximal muscle strength and power in major upper body muscles have not been investigated during gender‐affirming hormone therapy (GAHT). Objective To assess prospective changes in maximal muscle strength and muscle power from before and after 1 year of ...
Mathilde Kamp Nørlund, Jakob Lindberg Nielsen, Marianne Skovsager Andersen, Rikke Hjortebjerg, Laust Frisenberg Buhl, Anne Pernille Hermann, Camilla Viola Buskbjerg Palm, Tine Taulbjerg Kristensen, Jan Frystyk, Per Aagaard, Jonas Mathiesen, Dorte Glintborg, Louise Lehmann Christensen   +12 more
wiley   +1 more source

PB2673: EXPERIENCES AND VIEWS OF LEUKEMIA CARERS: A GLOBAL SURVEY

HemaSphere, 2023
Samantha Nier, Zack Pemberton-Whiteley, Nick York, Kathryn Huntley, Deborah Baker, Michael Rynne, Nicole Schroeter, Denis Costello, Lidija Pecova, Esther Natalie Oliva, Tatyana Ionova, Sam Salek   +11 more
doaj   +1 more source

PB1936: IDENTIFYING INEQUITIES IN SUPPORT - GLOBAL SURVEY OF PATIENT ORGANISATIONS DELIVERING SUPPORT SERVICES FOR CLL PATIENTS

HemaSphere, 2023
Deborah Baker, Nick York, Kathryn Huntley, Michael Rynne, Nicole Schroeter, Pierre Aumont, Brian Koffman, Felice Bombaci, Jennie Bradley, Lynsey Fenwick, Anna Schuh, Alina S. Gerrie, Norah O. Akinola, Yervand Hakobyan, Nicole Lamanna, Versha Banerji, Renata Walewska, Paolo Ghia   +17 more
doaj   +1 more source

Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)

OncoImmunology, 2018
Treatment with monoclonal antibodies has revolutionized clinical medicine, especially in the fields of cancer and immunology. One of the oldest antibodies, which is widely used for the treatment of lymphomas and autoimmune diseases, is the anti-CD20 ...
Shlomo Elias, Shira Kahlon, Rebecca Kotzur, Noah Kaynan, Ofer Mandelboim   +4 more
doaj   +1 more source

Ibrutinib-Induced Skin Rash

Turkish Journal of Hematology, 2021
Sudhir Kirar, Ajay Gogia, Ritu Gupta, Saumyaranjan mallick   +3 more
doaj   +1 more source

PNP inhibitors selectively kill cancer cells lacking SAMHD1

Molecular & Cellular Oncology, 2020
Purine nucleoside phosphorylase inhibitors (PNP-Is) were developed to ablate transformed lymphocytes. However, only some patients with leukemia benefit from PNP-Is. We provide a molecular explanation: the deoxyribonucleoside triphosphate (dNTP) hydrolase
Tamara Davenne, Jan Rehwinkel
doaj   +1 more source

Evidence for somatic selection of natural autoantibodies. [PDF]

, 1992
Natural autoantibodies are primarily immunoglobulin M (IgM) antibodies that bind to a variety of self-antigens, including self-IgG. Accounting for a large proportion of the early B cell repertoire, such polyspecific autoantibodies are speculated to ...
Carson, DA, Duffy, SF, Kipps, TJ, Martin, T   +3 more
core  

High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target [PDF]

, 2022
Laura Llaó Cid, JKL Wong, Iria Fernandez Botana, Yashna Paul, Marina Wierz, A Flörchinger, Susanne Gonder, Giulia Pagano, Margot Chazotte, Kresimir Bestak, Christoph Schifflers, Murat Iskar, Tobias Roider, Felix Czernilofsky, Bruch P-M, JP Mallm, Antonio Cosma, DE Campton, Elena Hartmann, Andreas Rosenwald, Dolors Colomer, Elı́as Campo, Denis Schapiro, Sascha Dietrich, Peter Lichter, Etienne Moussay, Jérôme Paggetti, Marc Zapatka, Martina Seiffert   +28 more
openalex   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies. [PDF]

Eur J Haematol
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Martino EA, Caserta S, Vigna E, Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F, Morabito F, Gentile M.   +10 more
europepmc   +2 more sources

¹⁸F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients [PDF]

, 2018
Sylvain Chantepie, Narinée Hovhannisyan, Stéphane Guillouet, Jean‐Pierre Pelage, Méziane Ibazizène, Caroline Bodet‐Milin, Thomas Carlier, Anne‐Claire Gac, Emilie Réboursière, Jean‐Pierre Vilque, Françoise Kraeber‐Bodéré, Alain Manrique, Gandhi Damaj, M Leporrier, Louisa Barré   +14 more
openalex   +1 more source